These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 23376083)

  • 21. Contribution of Fcgamma receptor IIIA gene 158V/F polymorphism and copy number variation to the risk of ACPA-positive rheumatoid arthritis.
    Thabet MM; Huizinga TW; Marques RB; Stoeken-Rijsbergen G; Bakker AM; Kurreeman FA; White SJ; Toes RE; van der Helm-van Mil AH
    Ann Rheum Dis; 2009 Nov; 68(11):1775-80. PubMed ID: 19019892
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Marked differences in CCR5 expression and activation levels in two South African populations.
    Picton AC; Shalekoff S; Paximadis M; Tiemessen CT
    Immunology; 2012 Aug; 136(4):397-407. PubMed ID: 22509959
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Enhancement of the antibody-dependent cellular cytotoxicity of low-fucose IgG1 Is independent of FcgammaRIIIa functional polymorphism.
    Niwa R; Hatanaka S; Shoji-Hosaka E; Sakurada M; Kobayashi Y; Uehara A; Yokoi H; Nakamura K; Shitara K
    Clin Cancer Res; 2004 Sep; 10(18 Pt 1):6248-55. PubMed ID: 15448014
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A comprehensive overview of FCGR3A gene variability by full-length gene sequencing including the identification of V158F polymorphism.
    Mahaweni NM; Olieslagers TI; Rivas IO; Molenbroeck SJJ; Groeneweg M; Bos GMJ; Tilanus MGJ; Voorter CEM; Wieten L
    Sci Rep; 2018 Oct; 8(1):15983. PubMed ID: 30374078
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Genetic linkage and association of Fcgamma receptor IIIA (CD16A) on chromosome 1q23 with human systemic lupus erythematosus.
    Edberg JC; Langefeld CD; Wu J; Moser KL; Kaufman KM; Kelly J; Bansal V; Brown WM; Salmon JE; Rich SS; Harley JB; Kimberly RP
    Arthritis Rheum; 2002 Aug; 46(8):2132-40. PubMed ID: 12209518
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Genetic susceptibility and haplotype analysis between Fcgamma receptor IIB and IIIA gene with systemic lupus erythematosus in Chinese population.
    Pan F; Tang X; Zhang K; Li X; Xu J; Chen H; Ye DQ
    Lupus; 2008 Aug; 17(8):733-8. PubMed ID: 18625651
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Polymorphism of FCGR3A gene in sarcoidosis.
    Typiak MJ; Rębała K; Dudziak M; Dubaniewicz A
    Hum Immunol; 2014 Apr; 75(4):283-8. PubMed ID: 24530756
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Variability at the FCGR locus: characterization in Black South Africans and evidence for ethnic variation in and out of Africa.
    Lassaunière R; Tiemessen CT
    Genes Immun; 2016 Mar; 17(2):93-104. PubMed ID: 26673965
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Association of FCGR3A and FCGR3B copy number variations with systemic lupus erythematosus and rheumatoid arthritis in Taiwanese patients.
    Chen JY; Wang CM; Chang SW; Cheng CH; Wu YJ; Lin JC; Yang B; Ho HH; Wu J
    Arthritis Rheumatol; 2014 Nov; 66(11):3113-21. PubMed ID: 25154742
    [TBL] [Abstract][Full Text] [Related]  

  • 30. NK Cell and Ig Interplay in Defense against Herpes Simplex Virus Type 1: Epistatic Interaction of CD16A and IgG1 Allotypes of Variable Affinities Modulates Antibody-Dependent Cellular Cytotoxicity and Susceptibility to Clinical Reactivation.
    Moraru M; Black LE; Muntasell A; Portero F; López-Botet M; Reyburn HT; Pandey JP; Vilches C
    J Immunol; 2015 Aug; 195(4):1676-84. PubMed ID: 26179905
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pyrosequencing for classification of human FcγRIIIA allotypes: a comparison with PCR-based techniques.
    Matlawska-Wasowska K; Gale JM; Nickl CK; Khalili P; Shirley B; Wilson BS; Vasef MA; Winter SS
    Mol Diagn Ther; 2014 Dec; 18(6):665-73. PubMed ID: 25230857
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Analysis of Fcgamma receptor haplotypes in rheumatoid arthritis: FCGR3A remains a major susceptibility gene at this locus, with an additional contribution from FCGR3B.
    Morgan AW; Barrett JH; Griffiths B; Subramanian D; Robinson JI; Keyte VH; Ali M; Jones EA; Old RW; Ponchel F; Boylston AW; Situnayake RD; Markham AF; Emery P; Isaacs JD
    Arthritis Res Ther; 2006; 8(1):R5. PubMed ID: 16356189
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Association study of copy number variants in FCGR3A and FCGR3B gene with risk of ankylosing spondylitis in a Chinese population.
    Wang L; Yang X; Cai G; Xin L; Xia Q; Zhang X; Li X; Wang M; Wang K; Xia G; Xu S; Xu J; Zou Y; Pan F
    Rheumatol Int; 2016 Mar; 36(3):437-42. PubMed ID: 26494566
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Impact of allele copy number of polymorphisms in FCGR3A and FCGR3B genes on susceptibility to ulcerative colitis.
    Asano K; Matsumoto T; Umeno J; Hirano A; Esaki M; Hosono N; Matsui T; Kiyohara Y; Nakamura Y; Kubo M; Kitazono T
    Inflamm Bowel Dis; 2013 Sep; 19(10):2061-8. PubMed ID: 23917248
    [TBL] [Abstract][Full Text] [Related]  

  • 35. FCGR2C genotyping by pyrosequencing reveals linkage disequilibrium with FCGR3A V158F and FCGR2A H131R polymorphisms in a Caucasian population.
    Lejeune J; Piègu B; Gouilleux-Gruart V; Ohresser M; Watier H; Thibault G
    MAbs; 2012; 4(6):784-7. PubMed ID: 23032993
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Fc γ receptor IIIa/CD16a processing correlates with the expression of glycan-related genes in human natural killer cells.
    Patel KR; Rodriguez Benavente MC; Lorenz WW; Mace EM; Barb AW
    J Biol Chem; 2021; 296():100183. PubMed ID: 33310702
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Genetic and Functional Profiling of CD16-Dependent Natural Killer Activation Identifies Patients at Higher Risk of Cardiac Allograft Vasculopathy.
    Paul P; Picard C; Sampol E; Lyonnet L; Di Cristofaro J; Paul-Delvaux L; Lano G; Nicolino-Brunet C; Ravis E; Collart F; Dignat-George F; Dussol B; Sabatier F; Mouly-Bandini A
    Circulation; 2018 Mar; 137(10):1049-1059. PubMed ID: 29097449
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Characterization of FcγRIIIA effector cells used in in vitro ADCC bioassay: Comparison of primary NK cells with engineered NK-92 and Jurkat T cells.
    Hsieh YT; Aggarwal P; Cirelli D; Gu L; Surowy T; Mozier NM
    J Immunol Methods; 2017 Feb; 441():56-66. PubMed ID: 27939300
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The loss of the CD16 B73.1/Leu11c epitope occurring in some primary immunodeficiency diseases is not associated with the FcgammaRIIIa-48L/R/H polymorphism.
    Lenart M; Trzyna E; Rutkowska M; Bukowska-Strakova K; Szaflarska A; Pituch-Noworolska A; Szczepanik A; Zembala M; Siedlar M
    Int J Mol Med; 2010 Sep; 26(3):435-42. PubMed ID: 20664961
    [TBL] [Abstract][Full Text] [Related]  

  • 40. FcγRIIIa expression on monocytes in rheumatoid arthritis: role in immune-complex stimulated TNF production and non-response to methotrexate therapy.
    Cooper DL; Martin SG; Robinson JI; Mackie SL; Charles CJ; Nam J; ; Isaacs JD; Emery P; Morgan AW
    PLoS One; 2012; 7(1):e28918. PubMed ID: 22235253
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.